Related Experiment Videos
[Serous-papillary endometrial carcinoma (clinico-morphological features)]
A F Urmancheeva1, E A Ul'rikh, E L Neustadt
1Medical Academy for Further Education, St. Petersburg.
Voprosy Onkologii
|January 18, 2003
Summary
Serous-papillary endometrial carcinoma (SPEC) presents with lower rates of obesity, diabetes, and infertility but shows more advanced stages and lymph node metastasis compared to endometrioid carcinoma (EEC). SPEC is suggested as a distinct clinico-morphological variant.
Area of Science:
- Gynecologic Oncology
- Pathology
- Cancer Research
Context:
- Serous-papillary endometrial carcinoma (SPEC) is a less common subtype of endometrial cancer.
- Understanding its distinct characteristics is crucial for accurate diagnosis and treatment.
- Comparison with endometrioid carcinoma (EEC) provides a benchmark for evaluating SPEC's unique features.
Purpose:
- To compare the clinicopathological features of SPEC and EEC.
- To identify risk factors and prognostic indicators specific to SPEC.
- To evaluate the potential classification of SPEC as a distinct pathogenetic variant.
Summary:
- SPEC accounts for 6.4% of endometrial cancers and exhibits lower incidences of obesity, diabetes, and infertility than EEC.
- SPEC patients more frequently present with advanced tumor stages (39.6% vs. 10.4%), deep stromal invasion (27.7% vs. 6.0%), and lymphogenous metastasis (13.9% vs. 4.1%).
- These findings support classifying SPEC as pathogenetic variant II.
Impact:
- Highlights the aggressive nature of SPEC compared to EEC.
- Informs clinical management strategies for SPEC patients.
- Contributes to a refined understanding of endometrial carcinoma subtypes and their classification.